Kill rate of mastitis pathogens by a combination of cefalexin and kanamycin

被引:12
作者
Maneke, E. [1 ]
Pridmore, A. [2 ]
Goby, L. [1 ]
Lang, I. [1 ]
机构
[1] Boehringer Ingelheim Vetmed GmbH, D-55218 Ingelheim, Germany
[2] Don Whitley Sci Ltd, Shipley, England
关键词
antibiotic treatment; cow; kill kinetics; mastitis; IN-VIVO; AMIKACIN; THERAPY;
D O I
10.1111/j.1365-2672.2010.04876.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aim: To assess the bacterial killing rate produced by a combination of cefalexin and kanamycin at two different concentration ratios. Methods and Results: Time-kill kinetics of cefalexin and kanamycin, individually and in combination, were determined against one strain each of Escherichia coli, Staphylococcus aureus, Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis. The combination was tested using two fixed ratios (cefalexin : kanamycin ratios of 1 center dot 25 : 1 and 1 : 2 center dot 3) and two concentrations of each ratio. Time-kill curves produced with either ratio were quite similar. Against most bacterial species, higher concentrations produced faster kill. In all cases, the combination of cefalexin and kanamycin showed faster and greater kill at lower antibiotic concentrations than those observed with either drug alone. Conclusions: The combination of cefalexin and kanamycin results in a fast initial killing of major mastitis pathogens at both concentration ratios. Significance and Impact of the Study: The combination of cefalexin and kanamycin achieved rapid bacterial kill at concentrations and ratios that can be achieved in vivo following intramammary infusion of a mastitis treatment.
引用
收藏
页码:184 / 190
页数:7
相关论文
共 17 条
[1]   Factors affecting cure when treating bovine clinical mastitis with cephalosporin-based intramammary preparations [J].
Bradley, A. J. ;
Green, M. J. .
JOURNAL OF DAIRY SCIENCE, 2009, 92 (05) :1941-1953
[2]   Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model [J].
Chan, E ;
Zhou, SF ;
Srikumar, S ;
Duan, W .
PHARMACEUTICAL RESEARCH, 2006, 23 (04) :729-741
[3]  
*CLSI, 1999, M26ACLSI
[4]  
FRANKLIN A, 1984, AM J VET RES, V45, P1398
[5]   Synergistic interactions between cefalexin and kanamycin in Mueller-Hinton broth medium and in milk [J].
Ganiere, J. P. ;
Denuault, L. .
JOURNAL OF APPLIED MICROBIOLOGY, 2009, 107 (01) :117-125
[6]  
GUDMUNDSSON S, 1991, SCAND J INFECT DIS, P80
[7]  
Jacobs Michael R., 2003, International Journal of Infectious Diseases, V7, pS13, DOI 10.1016/S1201-9712(03)90066-X
[8]   ACTIVITY OF AMIKACIN AND AMPICILLIN IN SUCCESSION AND IN COMBINATION [J].
LORIAN, V ;
ERNST, J .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1988, 11 (03) :163-169
[9]   Comparison of methods for assessing synergic antibiotic interactions [J].
Mackay, ML ;
Milne, K ;
Gould, IM .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 15 (02) :125-129
[10]  
MOLLER NF, 2002, INT J ANTIMICROB AG, V19, P333